What is Kura Oncology's current ratio?

Kura Oncology (KURA) reported current ratio of 6.1× in Q1 2026.

How has Kura Oncology's current ratio changed year-over-year?

Kura Oncology's current ratio decreased by 23.8% year-over-year, from 8.1× to 6.1×.

What is the long-term trend for Kura Oncology's current ratio?

Over 5 years (2020 to 2025), Kura Oncology's current ratio has grown at a -24.4% compound annual growth rate (CAGR), from 24.5× to 6.1×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Kura Oncology KURA Current ratio

Current ratio at other companies

Johnson & JohnsonJNJ

1×-0.2×

AmgenAMGN

1.3×+0.1×

ExelixisEXEL

3.3×-0.2×

Syndax PharmaceuticalsSNDX

5.5×-0.3×

AbbVieABBV

0.8×0.0×

Corvus PharmaceuticalsCRVS

19.8×+14.9×

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$942.78M+86.2%

Enterprise value$927.97M+95.5%

P/S13.2×+3.9×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Where this comes from

Calculated from Kura Oncology’s reported figures.

total current assets/total current liabilities=6.1×

Based on the most recent quarter.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's current ratio?: Kura Oncology (KURA) reported current ratio of 6.1× in Q1 2026.
How has Kura Oncology's current ratio changed year-over-year?: Kura Oncology's current ratio decreased by 23.8% year-over-year, from 8.1× to 6.1×.
What is the long-term trend for Kura Oncology's current ratio?: Over 5 years (2020 to 2025), Kura Oncology's current ratio has grown at a -24.4% compound annual growth rate (CAGR), from 24.5× to 6.1×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.